4D Molecular Therapeutics (FDMT) Preferred Shares Issued (2020)
4D Molecular Therapeutics (FDMT) reported Preferred Shares Issued of -$32000.0 for Q3 2020.
4D Molecular Therapeutics (FDMT) Preferred Shares Issued (2020) Analysis & Trends
4D Molecular Therapeutics (FDMT) has 1 years of Preferred Shares Issued data on file, last reported at -$32000.0 in Q3 2020.
- Preferred Shares Issued for Q3 2020 came in at -$32000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was -$32000.0 (changed N/A YoY), and the FY2020 annual result was $72.5 million, up 724780.0% from the prior year.
- Preferred Shares Issued steadied at -$32000.0 in Q3 2020 per FDMT's latest filing.
- Over five years, Preferred Shares Issued peaked at -$32000.0 in Q3 2020 and troughed at -$32000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | 4D Molecular Therapeutics | 656.48 Mn | 656.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -32,000.00 |
| Sep 30, 2020 | -32,000.00 |